Surgical Treatment of Congestive Heart Failure: Evolving Options

Annals of Thoracic Surgery

Volumn 76, Issue 6, 2003, Pages

  Griffith, Bartley P ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; HEALTH CARE COST; HEART ASSIST DEVICE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0345095483     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2003.09.008     Document Type: Conference Paper

References (59)

1. National Center for Health Statistics. Available at: www.cdc. gov/nchs/. Accessed May 2003.
2. Alderman DL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
3. Harris PJ, Harrel FE, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation 1979;60:1259.
4. Participants of VA Cooperative Study of Unstable Angina. Comparison of medical and surgical treatment for patients with unstable angina and poor left ventricular function [Abstract]. Abstracts of the 60th Scientific Sessions, American Heart Association, Anaheim Convention Center, November 16-19, 1987. Circulation 1987;76(Suppl 4):351.
5. Coles JG, Del Campo C, Ahmed SN, et al. Improved long-term survival following myocardial revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 1981;81:846-50.
6. Kaul TK, Agnihotri AK, Fields BL, Riggins LS, Wyatt DA, Jones CR. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 1996;111:1001-12.
7. Kron IL. When does one replace the heart in ischemic cardiomyopathy? Ann Thorac Surg 1993;55:581.
8. Luciani GB, Faggian TL, Razzolini R, Livi U, Bortolotti U, Mazzzucco A. Severe ischemic left ventricular failure: coronary operation or heart transplantation? Ann Thorac Surg 1993;55:719-23.
9. Yau TM, Fedak PWM, Weisel RD, et al. Predictors of operative risk for coronary bypass operations in patients with left ventricular dysfunction. J Thorac Cardiovasc Surg 1999;118:1006-13.
10. Baumgartner FJ, Omari BO, Goldberg S, et al. Coronary artery bypass grafting in patients with profound ventricular dysfunction. Tex Heart Inst J 1998;25:125-9.
11. Cimochowski GE, Harostock MD, Foldes PJ. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support. J Thorac Cardiovasc Surg 1997;113:655-66.
12. Elefteriades JA, Tolis G, Levi E, et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22:1411-7.
13. Hamer AW, Takayama M, Abraham KA, et al. End-systolic volume, and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. Circulation 1994;90:2899-904.
14. Dreyfus GD, Duboc D, Blasco A. Myocardial viability assess-ment in ischemic cardiomyopathy: benefits of coronary revascularization. Ann Thorac Surg 1994;57:1402-8.
15. Louie HW, Laks H, Milgalter E. Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. Circulation 1991;84(Suppl 3):290-5.
16. Bart BA, Shaw LK, McCants CB Jr, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 1997;30:1002-8.
17. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
18. Beller GA. Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation. J Nucl Cardiol 1997;4(Suppl):S152-7.
19. Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693-700.
20. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999;34:730-8.
21. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800.
22. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
23. Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998;32:921-6.
24. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999;33:1848-54.
25. Meluzin J, Cerny J, Frelich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1998;32:912-20.
26. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.
27. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
28. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
29. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000; 1002:1678-83.
30. 99mTc-sestamibi tomography before coronary artery bypass surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96:2892-8.
31. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM. Left ventricular end-systolic volume as the major determination of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
32. Migrino RQ, Young JB, Ellis SG, et al. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early, and late mortality. Circulation 1997;96:116-21.
33. Yamaguchi A, Ino T, Adachi H, et al. Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. Ann Thorac Surg 1998;65:434-8.
34. Weisman HF, Healy B. Myocardial infarct expansion and reinfarction: pathophysiologic concepts. Prog Cardio Dis 1987;30:73-110.
35. Likoff W, Bailey CP. Ventriculoplasty excision of myocardial aneurysm: report of a successful case. JAMA 1995;158:915.
36. Cooley DA, Collins HA, Morris GC, et al. Ventricular aneurysm after myocardial infarction: surgical excision with the use of temporary cardiopulmonary bypass. JAMA 1958;167: 557-60.
37. Hutchins GM, Brawley RK. The influence of cardiac geometry on the results of ventricular aneurysm repair. Am J Pathol 1980;99:221.
38. Stoney WS, Alford WC Jr, Burrus GR, et al. Repair of anteroseptal ventricular aneurysm. Ann Thorac Surg 1973; 15:394.
39. Jatene AD. Left ventricular aneurysmectomy. J Thorac Cardiovasc Surg 1985;89:321-31.
40. Dor V, Sabatier M, Donato MD, et al. Late hemodynamic results after left ventricular patch repair associated with coronary grafting in patients with post infarction akinetic or dyskinetic aneurysm of left ventricle. J Thorac Cardiovasc Surg 1995;110:1291-301.
41. Dor V, Saab M, Kornaszewska M, et al. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg 1989;37:11-9.
42. Cooley DA. Ventricular endoaneurysmorrhaphy: a simplified repair for extensive post infarction aneurysm. J Card Surg 1989;4:200.
43. Cooley DA, Frazier OH, Duncan JM, et al. Intracavitory repair of ventricular aneurysm and regional dyskinesia. Ann Surg 1992;215:417-24.
44. Buckberg GD. Basic science review: the helix and the heart. J Thorac Cardiovasc Surg 2002;124:863-83.
45. Athanasuleas CL, Stanley AW, Buckberg GD, Dor V, DiDonato M. Surgical anterior ventricular endocardial restoration (SAVER) for dilated ischemic cardiomyopathy. Semin Thorac Cardiovasc Surg 2001;13:448-58.
46. Sabbah HN, Maltsev VA, Chaudhry PA, Mishima T, Undrovinas AI. Contractile function of cardiomyocytes isolated from dogs with heart failure is enhanced after chronic therapy with passive ventricular constraint using the Acorn cardiac support device. Circulation 1999;100(Suppl):439.
47. Fukamachi K, Inoue M, Doik K, et al. Device based left ventricular geometry change for heart failure treatment. J Card Surg 2003;18(Suppl 2)543-47.
48. Kashem MA, Santamore, WP, Hassans et al. Cardioclasp: a new passive device to reshape cardiac enlargement. ASAIO J 2002;48:253-9.
49. Konertz W, Rombeck B, Zytowski M, et al. Clinical and hemodynamic short-term results with passive cardiomyoplasty [Abstract]. J Heart Lung Transplant 2000;19:68.
50. Kawaguchi AT. Partial left ventriculectomy - the third international registry report 2002. J Card Surg 2003;18(Suppl 2):533-42.
51. + gelling. J Am Coll Cardiol 2001;37(Suppl A):474.
52. Power JM, Raman J, Byrne M, Alferness CA. Passive ventricular constraint in advanced heart failure prevents a further decline in cardiovascular function [Abstract]. J Am Coll Cardiol 2000;35(Suppl A):233A.
53. Konertz W, Rombeck B, Hotz H, et al. Short-term safety of the Acorn cardiac support device in patients with advanced heart failure [Abstract]. J Am Coll Cardiol 2000;35(Suppl A):182A.
54. Kleber FX, Sonntag S, Krebs H, Stancke K, Rombeck B, Konertz W. Influence of the passive Acorn cardiac support device on systolic and diastolic left ventricular function [Abstract]. J Am Coll Cardiol 2000;35(Suppl A):182A.
55. David TE, Vden DC, Strauss HD. The importance of the mitral apparatus in left ventricular function after correction of MR. Circulation 1983;68:76-82.
56. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 2002;144:524-9.
57. Badhwar V, Bolling SF. Mitral valve surgery in the patient with left ventricular dysfunction. Semin Thorac Cardiovasc Surg 2002;14:133-6.
58. Bolling SF, Smolens IA, Pagani FD. Surgical alternatives for heart failure. J Heart Lung Transplant 2001;20:729-33.
59. International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: past, present and future. ISHLT 2002;21:945-39.